Business Context and Reporting Period
Aeva Technologies, Inc. was the target of a proposed business combination announced by InterPrivate Acquisition Corp. in a Form 8-K dated November 19, 2020. The transaction contemplated merging WLLY Merger Sub Corp., a wholly owned subsidiary of InterPrivate, with and into Aeva, with Aeva surviving as a wholly owned subsidiary of InterPrivate.
The filing was submitted under Item 8.01, Other Events, and included Exhibit 99.1, a form of investor presentation for discussions with stockholders and other persons. The filing issuer was InterPrivate Acquisition Corp., a Delaware special purpose acquisition company whose securities traded on the New York Stock Exchange.
Financial Metrics and Capital Structure
The filing does not provide clear figures for revenue, profit or loss, cash flow, margins, debt, liquidity, trust-account balances, valuation, or other operating metrics. It also does not provide a period-specific financial statement or a direct comparison with a prior comparable period.
The filing references a minimum trust-account amount following potential redemptions as a condition to closing, but does not state the applicable amount or expected post-transaction capitalization.
Material Changes Versus the Prior Comparable Period
No comparable-period financial or operating data is presented. The principal disclosed development is the proposed merger and related transaction process between InterPrivate and Aeva.
Outlook, Risks, Contingencies, and Unusual Items
- InterPrivate intended to file a Form S-4 registration statement containing a proxy statement, Aeva consent solicitation statement, and prospectus.
- Closing remained subject to stockholder approvals, satisfaction of the minimum trust-account condition after redemptions, required governmental and regulatory approvals, and other customary conditions.
- The transaction could fail to close on time or at all, including if InterPrivate could not complete the transaction by its business-combination deadline or obtain an extension.
- Disclosed risks included termination of the business combination agreement, litigation, disruption to Aeva’s business and employee retention, NYSE listing risks, competitive and regulatory pressures, product-development and commercialization delays, supplier and manufacturing issues, intellectual-property protection, product liability, and the need for additional capital.
- The filing specifically cautioned that Aeva may never achieve or sustain profitability and that additional financing may not be available on acceptable terms.
- The filing contains forward-looking statements regarding the transaction, Aeva’s products and markets, and projected future results. These statements were subject to substantial uncertainty and were not guarantees of performance.
- The filing was also designated as written communication under Rule 425 and stated that it was not itself a proxy solicitation, offer to sell, or solicitation of an offer to buy securities.
Investor Verification Items
- Review the later Form S-4, proxy and consent-solicitation materials for transaction terms, valuation, capitalization, projected results, and required approvals.
- Verify the minimum trust-account condition, expected redemption levels, available cash, and any financing requirements.
- Confirm whether the proposed transaction closed, was amended, terminated, or delayed, and whether the combined company obtained and maintained NYSE listing.
- Review Aeva’s historical financial statements and subsequent filings for revenue, losses, cash burn, liquidity, debt, capital needs, and commercialization progress.
- Assess the detailed risk factors concerning technology development, customer adoption, competition, regulation, suppliers, intellectual property, litigation, and profitability.